[Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)].
Bschleipfer
T
T
Klinik und Poliklinik für Urologie und Kinderurologie, Justus-Liebig-Universität, Rudolf-Buchheim-Strasse 7, 35385 Giessen.
Wagenlehner
F M E
FM
Weidner
W
W
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006801:Humans; D007267:Injections; D008297:Male; D010147:Pain Measurement; D017699:Pelvic Pain / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011472:Prostatitis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects; D000077409:Tamsulosin; D018084:Ultrasonography, Interventional
D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D019274:Botulinum Toxins, Type A; D000077409:Tamsulosin